Shares of Sorrento Therapeutics slid by a staggering 19.37% in 7 days from $9.03 to $7.28 at 20:48 EST on Tuesday, after four successive sessions in a row of losses. NASDAQ Composite is dropping 1.88% to $13,633.50, after three sequential sessions in a row of losses.

Sorrento Therapeutics’s last close was $7.91, 166.35% under its 52-week high of $19.39.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 123.4% for the present quarter and 119.1% for the next. The company’s growth estimates for the current quarter and the next is 205.6% and 213.9%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 11.7%, now sitting on 39.99M for the twelve trailing months.

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $7.28 at 20:48 EST, way below its 52-week high of $19.39 and way higher than its 52-week low of $2.18.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s value is way below its 50-day moving average of $10.00 and way under its 200-day moving average of $9.31.

More news about Sorrento Therapeutics.


Please enter your comment!
Please enter your name here